JERUSALEM and NEEDHAM, Massachusetts, June 26 /PRNewswire-FirstCall/ -- Oridion Systems Ltd. - (SWX: ORIDN) Oridion Medical, the leading developer and manufacturer of innovative capnography monitoring solutions, announced that it won the 2008 Manufacturers Partnership Award from IMDA, the association of medical specialty sales and marketing companies. With this award, IMDA acknowledges the Company's achievements in market development and support of its Specialty distributors (part of the Oridion Distribution Network) to increase their sales of Oridion capnography products.
The IMDA Manufacturers Partnership Award is given to the manufacturer that offers exceptional clinical and sales support, communicates frequently and openly with its Specialty distributors and responds promptly to questions, suggestions or problems. IMDA also recognized Oridion's excellent marketing as well as its active contribution to each dealer's increased revenues on the product line.
The IMDA distributor members vote on this award based on their experience with their manufacturers throughout the year. Tom Birmingham, IMDA Conference Chairman, highlighted Oridion's approach to the market by its involvement and support of major conferences and organizations like the APSF. "Oridion has high-quality support people in place and it maintains great presence at national shows," said Tom Birmingham. He added, "It also publishes excellent literature, CEU packages and educational material for the customer."
Dominic Verrilli III, Vice President of Clinical Technology, Inc. (a leading specialty distributor of medical products in the mid-western region of the United States) enthusiastically endorsed Oridion at the IMDA meeting. "Oridion provides exceptional clinical and sales supports. Their innovative Oridion Knowledge Center provides on-line clinical and sales training that is all-encompassing, simple to access and easy to use. The uniqueness of the "Capnography on Tour" marketing program has given us a foothold into new hospital areas and introduced us to new clinical champions for capnography that will help us increase our sales. Many of the companies we represent have solutions to future healthcare issues. In particular, Oridion's Microstream(R) EtCO2 technology provides the solution to a pressing patient-safety need, that is, the ability to safely monitor sedated patients!"
"Oridion is proud to have been recognized by IMDA," said Gerry Feldman, President of Oridion Capnography. "Our company's strengths are not only great products and customer support, but also the determination and creativity of our sales and clinical teams to provide our distributors with the best tools and programs to ensure growth in their sales. It aligns well with the Company's commitment to taking stress, risk and cost out of health care by improving patient safety with capnography."
Founded in 1978, IMDA is an association of sales, marketing and distribution organizations focused on bringing innovative medical technologies to market. For more information, visit http://www.imda.org
Oridion is the global leader of innovative capnography monitoring
solutions helping to improve patient safety, and its Microstream(R)
capnography technology has become the standard of care in ventilation
Next financial reporting:
August 18, 2008 Results Q2 / Half Year 2008
November 10, 2008 Results Q3 / Nine Months 2008
About Oridion Oridion Systems Ltd. (http://www.oridion.com) is a global medical device company specializing in patient safety monitoring. The Company operates through wholly owned subsidiaries in the United States, Europe, and Israel.
Oridion develops proprietary medical devices and patient interfaces, based on its patented Microstream(R) technologies, for the enhancement of patient safety through the monitoring of the carbon dioxide (CO2) in a patient's breath. These products provide effective, proven airway management and are used in various clinical environments, including procedural sedation, pain management, operating rooms, critical care units, post-anesthesia care units, emergency medical services, transport, alternate care and other settings where patients' ventilation may be compromised and at risk.
Certain statements made herein that are not historical are
forward-looking. The words "estimate" "project" "intend" "expect" "believe"
and similar expressions are intended to identify forward-looking
statements. These forward-looking statements involve known and unknown
risks and uncertainties. Many factors could cause the actual results,
performance or achievements of the Company to be materially different from
any future results, performance or achievements that may be expressed or
implied by such forward-looking statements, including, among others, our
ability to maintain profits, the market demands for our Capnography
products, our ability to focus our team on the Capnography business,
changes in general economic and business conditions, inability to maintain
market acceptance to the Company's products, inability to timely develop
and introduce new technologies, products and applications, rapid changes in
the market for the Company's products, loss of market share and pressure on
prices resulting from competition, introduction of competing products by
other companies, inability to manage growth and expansion, loss of key OEM
partners, factors effecting OEM partners' position in the market, inability
to attract and retain qualified personnel, inability to protect the
Company's proprietary technology.
For further information please contact:
Alan Adler, Chairman and Chief Executive Officer
Walter Tabachnik, Chief Financial Officer
Elena Gerberg, Investor Relations
address Oridion Systems Ltd.,
P.O. Box 45025,
|SOURCE Oridion Systems Ltd.|
Copyright©2008 PR Newswire.
All rights reserved